Morallos, Nor-ain C.

HRN: 29-35-18  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/21/2026
07/25/2026
IVT
500mg
Q8 C 7 Doses
S/p Primary Cs
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: